BX Swiss TOP 30 CHF
1.290,04
PKT
+5,07
PKT
+0,39
%
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
Datum | Rating | Analyst | |
---|---|---|---|
03.08.11 | Zurich Insurance hold | ING | |
03.08.11 | Nestlé buy | Vontobel Research | |
08.08.11 | Richemont hold | UniCredit Research | |
02.08.11 | ABB (Asea Brown Boveri) buy | Vontobel Research | |
02.08.11 | UBS hold | Vontobel Research | |
02.08.11 | UBS halten | Independent Research GmbH | |
01.08.11 | ABB (Asea Brown Boveri) buy | Citigroup Corp. | |
01.08.11 | Lonza hold | Citigroup Corp. | |
29.07.11 | Holcim hold | Citigroup Corp. | |
29.07.11 | Holcim buy | Société Générale Group S.A. (SG) | |
29.07.11 | UBS sell | Société Générale Group S.A. (SG) | |
29.07.11 | Logitech buy | Vontobel Research | |
29.07.11 | Nestlé buy | Vontobel Research | |
28.07.11 | UBS buy | Citigroup Corp. | |
28.07.11 | ABB (Asea Brown Boveri) kaufen | National-Bank AG | |
28.07.11 | Logitech sell | Citigroup Corp. | |
28.07.11 | Logitech buy | Vontobel Research | |
28.07.11 | Nestlé buy | Vontobel Research | |
28.07.11 | Lonza hold | Vontobel Research | |
28.07.11 | Holcim buy | Vontobel Research | |
28.07.11 | UBS hold | Vontobel Research | |
28.07.11 | UBS verkaufen | Independent Research GmbH | |
27.07.11 | UBS hold | Deutsche Bank AG | |
27.07.11 | Lonza hold | Citigroup Corp. | |
27.07.11 | UBS hold | Société Générale Group S.A. (SG) | |
27.07.11 | Novartis kaufen | Raiffeisen Centrobank AG | |
27.07.11 | UBS overweight | J.P. Morgan Cazenove | |
27.07.11 | Roche buy | UniCredit Research | |
27.07.11 | Holcim hold | UniCredit Research | |
26.07.11 | Swisscom buy | Société Générale Group S.A. (SG) | |
26.07.11 | Julius Bär outperform | Macquarie Research | |
26.07.11 | Sika buy | Vontobel Research | |
26.07.11 | UBS buy | Vontobel Research | |
26.07.11 | Adecco SA kaufen | Vontobel Research | |
26.07.11 | Roche kaufen | Hamburger Sparkasse AG (Haspa) | |
25.07.11 | ABB (Asea Brown Boveri) kaufen | Hamburger Sparkasse AG (Haspa) | |
25.07.11 | ABB (Asea Brown Boveri) outperform | Macquarie Research | |
25.07.11 | Julius Bär outperform | Macquarie Research | |
25.07.11 | Novartis buy | Vontobel Research | |
25.07.11 | Julius Bär hold | Vontobel Research |